Key result
Spironolactone corrects hypertension and metabolic deficits in primary aldosteronism, accurately predicting surgical response.
Observational
Answers are grounded in this paper and cite their sources.
Hyperaldosteronism causes the hypertension and metabolic abnormalities characteristic of primary aldosteronism. Hyperaldosteronism does not cause the hypertension of patients with secondary aldosteronism but may be responsible for certain electrolyte abnormalities generally associated with aldosterone excess. In view of this, elimination of excess aldosterone either by adrenalectomy or as reported here by pharmacologic blockade with high dose (400 mg/day), long-term (3 to 5 weeks) spironolactone corrects both the hypertension and metabolic abnormalities of primary aldosteronism but only reverses the metabolic abnormalities and does not relieve the hypertension of secondary aldosteronism. Thus, preoperative treatment with high-dose, long-term spironolactone therapy accurately predicts the response that might be expected after adrenal surgery.
No takes yet. Share an insight, caveat, or question.
Richard F. Spark (1968) conducted an observational in Primary and secondary aldosteronism with hypertension. Spironolactone was evaluated on Correction of hypertension and metabolic abnormalities. Spironolactone corrects both hypertension and metabolic abnormalities in primary aldosteronism, accurately predicting response to adrenalectomy.
Synapse has enriched 10 related papers. Consider them for comparative context: